The U.S. takes forever to approve drugs before they can be sold to the public, but no such caution is taken with new devices.

Big companies are self-insuring themselves and taking other steps to control medical costs. Is this a return to plantation days?

Hospitals and patients would save money if the two options were offered in one venue, because many people go to ERs for nonemergencies.

Cost controls on the pharmaceutical industry are sorely needed as testing and treatment advance.

It’s time for the federal program to eliminate a rule that prevents timely transfers of patients from hospitals to skilled nursing facilities.

Amazon and Walmart are among the giant companies that may be bringing their penchants for efficiency into the world of health care.

A national database for health records would greatly reduce duplicate lab work and diagnostic testing — not to mention overmedication.

A sophisticated solicitation can convince a patient to ask for unneeded equipment, and trick a doctor’s office into going along with it.

You may get out of the pharmacy with pills in hand and money still in your wallet, but the high cost of medication will get you in the end.

Technology makes medical information available faster these days, but should it be accessible to patients without a doctor’s explanation?

As we desperately seek alternatives to addictive painkillers, a federal ban on research is obstructing one promising option.

Employers waste money requiring their workers to have physicians verify that they were legitimately sick and have now recovered.